BR112018068522A2 - novas proteínas derivadas de alfa-1-microglobulina e seu uso - Google Patents

novas proteínas derivadas de alfa-1-microglobulina e seu uso

Info

Publication number
BR112018068522A2
BR112018068522A2 BR112018068522A BR112018068522A BR112018068522A2 BR 112018068522 A2 BR112018068522 A2 BR 112018068522A2 BR 112018068522 A BR112018068522 A BR 112018068522A BR 112018068522 A BR112018068522 A BR 112018068522A BR 112018068522 A2 BR112018068522 A2 BR 112018068522A2
Authority
BR
Brazil
Prior art keywords
microglobulin
alpha
proteins derived
new proteins
new
Prior art date
Application number
BR112018068522A
Other languages
English (en)
Portuguese (pt)
Inventor
Edström Hägerwall Anneli
Åkerström Bo
Wester Rosenlöf Lena
Original Assignee
A1M Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A1M Pharma Ab filed Critical A1M Pharma Ab
Publication of BR112018068522A2 publication Critical patent/BR112018068522A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717Plasma globulins, lactoglobulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
BR112018068522A 2016-03-18 2017-03-17 novas proteínas derivadas de alfa-1-microglobulina e seu uso BR112018068522A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (1)

Publication Number Publication Date
BR112018068522A2 true BR112018068522A2 (pt) 2019-01-22

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068522A BR112018068522A2 (pt) 2016-03-18 2017-03-17 novas proteínas derivadas de alfa-1-microglobulina e seu uso

Country Status (15)

Country Link
US (1) US10981963B2 (enExample)
EP (1) EP3430032B1 (enExample)
JP (1) JP6976579B2 (enExample)
KR (1) KR102437662B1 (enExample)
CN (1) CN108779157B (enExample)
AU (1) AU2017235608B2 (enExample)
BR (1) BR112018068522A2 (enExample)
CA (1) CA3017836A1 (enExample)
EA (1) EA039776B1 (enExample)
ES (1) ES2896734T3 (enExample)
MX (1) MX2018011193A (enExample)
NZ (1) NZ746677A (enExample)
SG (1) SG11201807352XA (enExample)
WO (1) WO2017158181A1 (enExample)
ZA (1) ZA201805797B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511386A (zh) * 2017-11-03 2020-08-07 卫士医疗国际公司 α-1-微球蛋白用于保护骨髓细胞的用途
WO2024165674A1 (en) 2023-02-08 2024-08-15 Guard Therapeutics International AB Alpha-1-microglobulin derived peptide fragments and uses thereof
US12227343B2 (en) * 2023-03-17 2025-02-18 Blue Buffalo Enterpises, Inc. Retail ready opening feature for e-commerce carton

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2313106B1 (en) * 2008-07-18 2016-03-30 A1M Pharma AB Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
WO2013113851A1 (en) * 2012-01-31 2013-08-08 Technische Universitaet Muenchen Muteins of a1m lipocalin and method of production therefor
ES2599034T3 (es) * 2012-09-05 2017-01-31 A1M Pharma Ab Alfa-1-microglobulina para su uso en el tratamiento de enfermedades relacionadas con mitocondrias
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Also Published As

Publication number Publication date
SG11201807352XA (en) 2018-09-27
ES2896734T3 (es) 2022-02-25
WO2017158181A1 (en) 2017-09-21
JP2019519466A (ja) 2019-07-11
NZ746677A (en) 2023-02-24
EP3430032A1 (en) 2019-01-23
CN108779157B (zh) 2022-12-30
US10981963B2 (en) 2021-04-20
US20190161524A1 (en) 2019-05-30
EA201892085A1 (ru) 2019-02-28
KR102437662B1 (ko) 2022-08-29
EP3430032B1 (en) 2021-09-01
EA039776B1 (ru) 2022-03-11
CN108779157A (zh) 2018-11-09
ZA201805797B (en) 2022-03-30
CA3017836A1 (en) 2017-09-21
AU2017235608A1 (en) 2018-10-18
MX2018011193A (es) 2019-03-28
JP6976579B2 (ja) 2021-12-08
KR20180127411A (ko) 2018-11-28
AU2017235608B2 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
CY1124106T1 (el) Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων
CY1122898T1 (el) Απεκκριση πολυπεπτιδιων που περιεχουν αιμη
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
MX2024011869A (es) Anticuerpos anti-tau y metodos de uso
CL2016001871A1 (es) Anticuerpos humanos para pd-1
MX2017007049A (es) Anticuerpos anti-cd79b y métodos de uso.
PT3694529T (pt) Proteínas triespecíficas e métodos de utilização
MX2021008376A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
HUE065695T2 (hu) Szövet életképesség mérése
CR20190271A (es) Anticuerpos antitau y métodos de uso
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
MX2016010433A (es) Anticuerpos anti-jagged1 y metodos de uso.
EP3544997A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN
MX2016014247A (es) Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7).
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
MX2016009555A (es) Proteinas de union y metodos para utilizarlas.
CR20170095A (es) Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas
BR112017013608B8 (pt) Picolinamidas como fungicidas
BR112016025397A2 (pt) picolinamidas macrocíclicas como fungicidas
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
EA201892568A1 (ru) Способы получения контрастных средств для ультразвукового исследования
EP3522698A4 (en) NEW INSECTICIDE PROTEINS
EP3075340C0 (de) Gewebeschere für biologisches Gewebe
AR101671A1 (es) Anticuerpos anti proteína similar a angiopoyetina-4 (angptl4) y métodos de uso
BR112018068522A2 (pt) novas proteínas derivadas de alfa-1-microglobulina e seu uso

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: GUARD THERAPEUTICS INTERNATIONAL AB (SE)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B25G Requested change of headquarter approved

Owner name: GUARD THERAPEUTICS INTERNATIONAL AB (SE)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]